<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="1.3" id="eji5988" xml:lang="en" article-type="other"><?properties open_access?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Eur J Immunol</journal-id><journal-id journal-id-type="iso-abbrev">Eur J Immunol</journal-id><journal-id journal-id-type="doi">10.1002/(ISSN)1521-4141</journal-id><journal-id journal-id-type="publisher-id">EJI</journal-id><journal-title-group><journal-title>European Journal of Immunology</journal-title></journal-title-group><issn pub-type="ppub">0014-2980</issn><issn pub-type="epub">1521-4141</issn><publisher><publisher-name>John Wiley and Sons Inc.</publisher-name><publisher-loc>Hoboken</publisher-loc></publisher></journal-meta>
<article-meta><article-id pub-id-type="pmid">40405475</article-id><article-id pub-id-type="pmc">PMC12099177</article-id><article-id pub-id-type="doi">10.1002/eji.202451666</article-id><article-id pub-id-type="publisher-id">EJI5988</article-id><article-categories><subj-group subj-group-type="overline"><subject>Technical Report</subject></subj-group><subj-group subj-group-type="heading"><subject>Technical Report</subject><subj-group subj-group-type="heading"><subject>Basic</subject></subj-group></subj-group></article-categories><title-group><article-title>Linking Epitope&#x02010;Specific T&#x02010;Cell Receptors to IFN&#x003b3; Secretion Using Nanovial Technology</article-title></title-group><contrib-group><contrib id="eji5988-cr-0001" contrib-type="author"><name><surname>van den Dijssel</surname><given-names>Jet</given-names></name><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-4849-0374</contrib-id><xref rid="eji5988-aff-0001" ref-type="aff">
<sup>1</sup>
</xref><xref rid="eji5988-aff-0002" ref-type="aff">
<sup>2</sup>
</xref><xref rid="eji5988-aff-0003" ref-type="aff">
<sup>3</sup>
</xref></contrib><contrib id="eji5988-cr-0002" contrib-type="author"><name><surname>Menon</surname><given-names>Tejas</given-names></name><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0001-7636-0051</contrib-id><xref rid="eji5988-aff-0003" ref-type="aff">
<sup>3</sup>
</xref></contrib><contrib id="eji5988-cr-0003" contrib-type="author"><name><surname>McQuilten</surname><given-names>Hayley A.</given-names></name><xref rid="eji5988-aff-0003" ref-type="aff">
<sup>3</sup>
</xref></contrib><contrib id="eji5988-cr-0004" contrib-type="author"><name><surname>Eltherington</surname><given-names>Oliver</given-names></name><xref rid="eji5988-aff-0003" ref-type="aff">
<sup>3</sup>
</xref><xref rid="eji5988-aff-0004" ref-type="aff">
<sup>4</sup>
</xref></contrib><contrib id="eji5988-cr-0005" contrib-type="author"><name><surname>Gonzalez</surname><given-names>Alexis</given-names></name><xref rid="eji5988-aff-0003" ref-type="aff">
<sup>3</sup>
</xref><xref rid="eji5988-aff-0004" ref-type="aff">
<sup>4</sup>
</xref></contrib><contrib id="eji5988-cr-0006" contrib-type="author"><name><surname>Baghdasarian</surname><given-names>Sevana</given-names></name><xref rid="eji5988-aff-0005" ref-type="aff">
<sup>5</sup>
</xref></contrib><contrib id="eji5988-cr-0007" contrib-type="author"><name><surname>Soemardy</surname><given-names>Citradewi</given-names></name><xref rid="eji5988-aff-0006" ref-type="aff">
<sup>6</sup>
</xref></contrib><contrib id="eji5988-cr-0008" contrib-type="author"><name><surname>Di Carlo</surname><given-names>Dino</given-names></name><xref rid="eji5988-aff-0006" ref-type="aff">
<sup>6</sup>
</xref><xref rid="eji5988-aff-0007" ref-type="aff">
<sup>7</sup>
</xref><xref rid="eji5988-aff-0008" ref-type="aff">
<sup>8</sup>
</xref><xref rid="eji5988-aff-0009" ref-type="aff">
<sup>9</sup>
</xref></contrib><contrib id="eji5988-cr-0009" contrib-type="author"><name><surname>van Gisbergen</surname><given-names>Klaas P.J.M.</given-names></name><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0003-3623-7555</contrib-id><xref rid="eji5988-aff-0001" ref-type="aff">
<sup>1</sup>
</xref><xref rid="eji5988-aff-0010" ref-type="aff">
<sup>10</sup>
</xref></contrib><contrib id="eji5988-cr-0010" contrib-type="author"><name><surname>ten Brinke</surname><given-names>Anja</given-names></name><xref rid="eji5988-aff-0001" ref-type="aff">
<sup>1</sup>
</xref><xref rid="eji5988-aff-0002" ref-type="aff">
<sup>2</sup>
</xref></contrib><contrib id="eji5988-cr-0011" contrib-type="author" corresp="yes"><name><surname>van de Sandt</surname><given-names>Carolien E.</given-names></name><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-4155-7433</contrib-id><xref rid="eji5988-aff-0003" ref-type="aff">
<sup>3</sup>
</xref><address><email>cvandesandt@unimelb.edu.au</email></address></contrib></contrib-group><aff id="eji5988-aff-0001">
<label>
<sup>1</sup>
</label>
<named-content content-type="organisation-division">Sanquin Research and Landsteiner Laboratory, Amsterdam UMC</named-content>
<institution>University of Amsterdam</institution>
<city>Amsterdam</city>
<country country="NL">The Netherlands</country>
</aff><aff id="eji5988-aff-0002">
<label>
<sup>2</sup>
</label>
<institution>Amsterdam</institution>
<institution>Institute for Immunology and Infectious Diseases</institution>
<city>Amsterdam</city>
<country country="NL">The Netherlands</country>
</aff><aff id="eji5988-aff-0003">
<label>
<sup>3</sup>
</label>
<named-content content-type="organisation-division">Department of Microbiology and Immunology</named-content>
<institution>University of Melbourne at the Peter Doherty Institute for Infection and Immunity</institution>
<city>Melbourne</city>
<country country="AU">Australia</country>
</aff><aff id="eji5988-aff-0004">
<label>
<sup>4</sup>
</label>
<named-content content-type="organisation-division">Melbourne Cytometry Platform</named-content>
<institution>University of Melbourne</institution>
<city>Melbourne</city>
<country country="AU">Australia</country>
</aff><aff id="eji5988-aff-0005">
<label>
<sup>5</sup>
</label>
<named-content content-type="organisation-division">Department of Chemical and Biomolecular Engineering</named-content>
<institution>University of California Los Angeles</institution>
<city>Los Angeles</city>
<named-content content-type="country-part">California</named-content>
<country country="US">USA</country>
</aff><aff id="eji5988-aff-0006">
<label>
<sup>6</sup>
</label>
<named-content content-type="organisation-division">Department of Bioengineering</named-content>
<institution>University of California Los Angeles</institution>
<city>Los Angeles</city>
<named-content content-type="country-part">California</named-content>
<country country="US">USA</country>
</aff><aff id="eji5988-aff-0007">
<label>
<sup>7</sup>
</label>
<institution>Partillion Bioscience</institution>
<city>Pasadena</city>
<named-content content-type="country-part">California</named-content>
<country country="US">USA</country>
</aff><aff id="eji5988-aff-0008">
<label>
<sup>8</sup>
</label>
<named-content content-type="organisation-division">Department of Mechanical and Aerospace Engineering</named-content>
<institution>University of California Los Angeles</institution>
<city>Los Angeles</city>
<named-content content-type="country-part">California</named-content>
<country country="US">USA</country>
</aff><aff id="eji5988-aff-0009">
<label>
<sup>9</sup>
</label>
<named-content content-type="organisation-division">California NanoSystems Institute (CNSI)</named-content>
<institution>University of California Los Angeles</institution>
<city>Los Angeles</city>
<named-content content-type="country-part">California</named-content>
<country country="US">USA</country>
</aff><aff id="eji5988-aff-0010">
<label>
<sup>10</sup>
</label>
<named-content content-type="organisation-division">Physiology and Cancer Programme, Champalimaud Research</named-content>
<institution>Champalimaud Foundation</institution>
<city>Lisbon</city>
<country country="PT">Portugal</country>
</aff><pub-date pub-type="epub"><day>22</day><month>5</month><year>2025</year></pub-date><pub-date pub-type="ppub"><month>5</month><year>2025</year></pub-date><volume>55</volume><issue seq="130">5</issue><issue-id pub-id-type="doi">10.1002/eji.v55.5</issue-id><elocation-id>e202451666</elocation-id><history>
<date date-type="rev-recd"><day>01</day><month>5</month><year>2025</year></date>
<date date-type="received"><day>29</day><month>11</month><year>2024</year></date>
<date date-type="accepted"><day>05</day><month>5</month><year>2025</year></date>
</history><permissions><!--&#x000a9; 2025 Wiley&#x02010;VCH GmbH--><copyright-statement content-type="article-copyright">&#x000a9; 2025 The Author(s). <italic toggle="yes">European Journal of Immunology</italic> published by Wiley&#x02010;VCH GmbH.</copyright-statement><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This is an open access article under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link> License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="file:EJI-55-e202451666.pdf"/><abstract id="eji5988-abs-0001" abstract-type="graphical"><p>To link IFN&#x003b3;&#x02010;secretion levels of epitope&#x02010;specific T&#x02010;cells with their TCR&#x003b1;&#x003b2;, we coated nanovials with pHLA&#x02010;I to capture and activate epitope&#x02010;specific T&#x02010;cells and their secreted IFN&#x003b3;, followed by index&#x02010;sorting and TCR&#x003b1;&#x003b2; sequencing. We demonstrate that nanovials are a promising tool to link single epitope&#x02010;specific TCR&#x003b1;&#x003b2; clonotypes to the cell's functional properties.
<boxed-text position="anchor" content-type="graphic"><graphic xlink:href="EJI-55-e202451666-g001.jpg" position="anchor" id="jats-graphic-1"/></boxed-text>
</p></abstract><kwd-group kwd-group-type="author-generated"><kwd id="eji5988-kwd-0001">cytokine secretion</kwd><kwd id="eji5988-kwd-0002">epitope&#x02010;specific CD8<sup>+</sup> T&#x02010;cells</kwd><kwd id="eji5988-kwd-0003">nanovials</kwd><kwd id="eji5988-kwd-0004">T&#x02010;cell receptor</kwd></kwd-group><funding-group><award-group id="funding-0001"><funding-source><institution-wrap><institution>Stichting Sanquin Bloedvoorziening
</institution><institution-id institution-id-type="doi">10.13039/501100012023</institution-id></institution-wrap></funding-source><award-id>L2506</award-id></award-group><award-group id="funding-0002"><funding-source><institution-wrap><institution>Australian Research Council
</institution><institution-id institution-id-type="doi">10.13039/501100000923</institution-id></institution-wrap></funding-source><award-id>DE220100185</award-id></award-group><award-group id="funding-0003"><funding-source><institution-wrap><institution>University of Melbourne
</institution><institution-id institution-id-type="doi">10.13039/501100001782</institution-id></institution-wrap></funding-source><award-id>Establishment_Grant</award-id></award-group><award-group id="funding-0004"><funding-source>Chan Zuckerberg Initiative Silicon Valley Community Foundation</funding-source><award-id>2023&#x02010;332386</award-id></award-group></funding-group><counts><fig-count count="2"/><table-count count="0"/><page-count count="4"/><word-count count="2268"/></counts><custom-meta-group><custom-meta><meta-name>source-schema-version-number</meta-name><meta-value>2.0</meta-value></custom-meta><custom-meta><meta-name>cover-date</meta-name><meta-value>May 2025</meta-value></custom-meta><custom-meta><meta-name>details-of-publishers-convertor</meta-name><meta-value>Converter:WILEY_ML3GV2_TO_JATSPMC version:6.5.6 mode:remove_FC converted:23.05.2025</meta-value></custom-meta></custom-meta-group></article-meta><notes><fn-group><fn id="eji5988-note-0001"><p>
<bold>Funding</bold>: The research received support from Stichting Sanquin Bloedvoorziening L2506, Australian Research Council DE220100185, the University of Melbourne Establishment Grant, Chan Zuckerberg initiative Silicon Valley Community Foundation advise fund 2023&#x02010;332386.</p></fn></fn-group></notes></front><body><def-list list-content="abbreviations" id="eji5988-dl-0001"><title>Abbreviations</title><def-item><term>A2</term><def><p>HLA&#x02010;A*02:01</p></def></def-item><def-item><term>CDR</term><def><p>complementarity&#x02010;determining region</p></def></def-item><def-item><term>ICS</term><def><p>intracellular cytokine staining</p></def></def-item><def-item><term>IFN&#x003b3;</term><def><p>interferon&#x02010;gamma</p></def></def-item><def-item><term>IL&#x02010;2</term><def><p>interleukin&#x02010;2</p></def></def-item><def-item><term>pHLA&#x02010;I</term><def><p>peptide bound to human leukocyte antigen class&#x02010;I</p></def></def-item><def-item><term>TCR</term><def><p>T&#x02010;cell receptor</p></def></def-item><def-item><term>TNF</term><def><p>tumor necrosis factor</p></def></def-item></def-list><p>CD8<sup>+</sup> T&#x02010;cells play a key role in controlling viral infections by eliminating virus&#x02010;infected cells. Their T&#x02010;cell receptor (TCR) recognizes epitopes (peptides bound to HLA class&#x02010;I (pHLA&#x02010;I)) on the infected cell surface. This results in CD8<sup>+</sup> T&#x02010;cell activation, including cytokine secretion, like interferon&#x02010;gamma (IFN&#x003b3;), differentiation, and memory formation [<xref rid="eji5988-bib-0001" ref-type="bibr">1</xref>, <xref rid="eji5988-bib-0002" ref-type="bibr">2</xref>]. TCRs affect the functionality, phenotype, and secretory function of epitope&#x02010;specific CD8<sup>+</sup> T&#x02010;cells [<xref rid="eji5988-bib-0001" ref-type="bibr">1</xref>, <xref rid="eji5988-bib-0003" ref-type="bibr">3</xref>, <xref rid="eji5988-bib-0004" ref-type="bibr">4</xref>]. However, linking TCR clonotypes directly to functionality, as determined by cytokine secretion, remains technically challenging.</p><p>Cytokine production upon epitope&#x02010;specific CD8<sup>+</sup> T&#x02010;cell activation can be assessed by combining pHLA&#x02010;tetramers with intracellular cytokine staining (ICS) [<xref rid="eji5988-bib-0001" ref-type="bibr">1</xref>, <xref rid="eji5988-bib-0005" ref-type="bibr">5</xref>]. However, the required fixation and permeabilization degrades mRNA, making additional paired&#x02010;TCR&#x003b1;&#x003b2; analysis challenging. Some studies successfully sequenced cytokine mRNA after ICS; however, its suitability for sensitive paired&#x02010;TCR&#x003b1;&#x003b2; sequencing remains unclear [<xref rid="eji5988-bib-0006" ref-type="bibr">6</xref>]. Single&#x02010;cell transcriptomics links TCRs with cytokine mRNA levels, but mRNA levels poorly correlate with secreted cytokine levels [<xref rid="eji5988-bib-0007" ref-type="bibr">7</xref>]. The cytokine&#x02010;catch assay utilizes antibodies that simultaneously bind unfixed T&#x02010;cell and secreted cytokines, making it compatible with the TCR&#x003b1;&#x003b2;&#x02010;multiplex. However, secreted cytokines can be captured by antibodies on noncytokine&#x02010;producing cells resulting in false positives [<xref rid="eji5988-bib-0008" ref-type="bibr">8</xref>]. Therefore, new technologies are required to unequivocally link cytokine&#x02010;secretion levels to their TCR.</p><p>Nanovial technology uses cavity&#x02010;containing hydrogel microparticles to capture cells and their secreted cytokines [<xref rid="eji5988-bib-0009" ref-type="bibr">9</xref>, <xref rid="eji5988-bib-0010" ref-type="bibr">10</xref>]. The nanovial cavity is coated with antibodies that bind molecules expressed on the surface of cells of interest. Nanovials can also be coated by pHLA&#x02010;I complexes (monomers) which bind TCRs and simultaneously activate cells in an epitope&#x02010;specific manner (Figure&#x000a0;<xref rid="eji5988-fig-0001" ref-type="fig">1A</xref>). Additional anti&#x02010;cytokine antibodies also coat the nanovial&#x02010;cavity to catch secreted cytokines. Their cup&#x02010;like structure prevents spillover of secreted cytokines to neighboring cells [<xref rid="eji5988-bib-0009" ref-type="bibr">9</xref>, <xref rid="eji5988-bib-0010" ref-type="bibr">10</xref>]. Following incubation to allow cytokine secretion, nanovials are stained using Calcein&#x02010;AM (a live&#x02010;cell stain to separate empty from cell&#x02010;loaded nanovials), and fluorescent antibodies to detect the cytokine and cell surface markers. Nanovials containing cytokine&#x02010;secreting cells can be (single&#x02010;cell) sorted, without fixation or permeabilization, allowing further cell culture or adoptive transfer [<xref rid="eji5988-bib-0010" ref-type="bibr">10</xref>]. Importantly, cells can be used for TCR&#x003b1;&#x003b2; or scRNA sequencing, to link cytokine&#x02010;secretion levels with TCR or gene&#x02010;expression profiles. However, it remains unclear how nanovial technology compares to conventional ICS.</p><fig position="float" fig-type="FIGURE" id="eji5988-fig-0001"><label>FIGURE 1</label><caption><p>Nanovial&#x02010;captured and activated A2/M1<sub>58</sub>&#x02010;specific CD8<sup>+</sup> T&#x02010;cells secrete IFN&#x003b3;. (A) Workflow of the ICS and nanovial assays; created with BioRender. Representative gating strategy of the (B) nanovial assay and (C) ICS, full gating strategy in Figure S1. Frequency and number of (D) nanovial or tetramer&#x02010;bound CD8<sup>+</sup> T&#x02010;cells or (E) IFN&#x003b3;&#x02010;secreting (nanovial) and IFN&#x003b3;&#x02010;producing (ICS) A2/M1<sub>58</sub>&#x02010;specific CD8<sup>+</sup> T&#x02010;cells. Nanovials <italic toggle="yes">n</italic> = 8, ICS <italic toggle="yes">n</italic> = 3 conditions, measured across 5 and 2 experiments respectively. Similar conditions were measured across independent experiments. Horizontal lines indicate the median. Statistical analysis by the unpaired Mann&#x02013;Whitney <italic toggle="yes">U</italic>&#x02010;test. Significant <italic toggle="yes">p</italic>&#x02010;values are displayed above the graphs.</p></caption><graphic xlink:href="EJI-55-e202451666-g002" position="anchor" id="jats-graphic-3"/></fig><p>Nanovials were coated with anti&#x02010;IFN&#x003b3; antibodies and the prominent and high&#x02010;affinity influenza HLA&#x02010;A*02:01&#x02010;M1<sub>58&#x02010;66</sub> (A2/M1<sub>58</sub>) epitope [<xref rid="eji5988-bib-0001" ref-type="bibr">1</xref>, <xref rid="eji5988-bib-0011" ref-type="bibr">11</xref>, <xref rid="eji5988-bib-0012" ref-type="bibr">12</xref>] to capture and activate A2/M1<sub>58</sub>&#x02010;specific CD8<sup>+</sup> T&#x02010;cells. Modified nanovials were incubated with in vitro A2/M1<sub>58</sub>&#x02010;expanded CD8<sup>+</sup> T&#x02010;cells in a 1.6 to 1 ratio (64,000 nanovials to 40,000 cells) (Figure&#x000a0;<xref rid="eji5988-fig-0001" ref-type="fig">1A</xref>). Modified nanovials incubated with recombinant IFN&#x003b3; (rIFN&#x003b3;) and empty nanovials served as positive and negative controls, respectively (Figure&#x000a0;<xref rid="eji5988-fig-0001" ref-type="fig">1A,B</xref>; Figure <xref rid="eji5988-supinfo-0001" ref-type="">S1A</xref>). Different conditions, including nanovial modification volumes, cell incubation formats, and incubation times were assessed to optimize epitope&#x02010;specific CD8<sup>+</sup> T&#x02010;cell&#x02010;nanovial binding (Figure <xref rid="eji5988-supinfo-0001" ref-type="">S2A</xref>). A 3&#x000a0;h incubation resulted in significantly higher CD8<sup>+</sup> T&#x02010;cell&#x02010;loaded nanovial numbers compared with a 5&#x000a0;h incubation (Figure <xref rid="eji5988-supinfo-0001" ref-type="">S2B</xref>), with significantly more medium&#x02010; and high&#x02010;secreting cells (Figure <xref rid="eji5988-supinfo-0001" ref-type="">S2C</xref>). This suggests that A2/M1<sub>58</sub>&#x02010;specific CD8<sup>+</sup> T&#x02010;cells might dissociate from nanovials over time. Other optimizations did not considerably impact T&#x02010;cell loading. Concurrently, expanded A2/M1<sub>58</sub>&#x02010;specific CD8<sup>+</sup> T&#x02010;cells were re&#x02010;stimulated with M1<sub>58&#x02010;66</sub> peptide, PMA/Ionomycin (positive control), or DMSO (negative control) to access IFN&#x003b3;&#x02010;production by ICS (Figure&#x000a0;<xref rid="eji5988-fig-0001" ref-type="fig">1A,C</xref>; Figure <xref rid="eji5988-supinfo-0001" ref-type="">S1B</xref>). IFN&#x003b3;<sup>+</sup>A2/M1<sub>58</sub>
<sup>+</sup>CD8<sup>+</sup> T&#x02010;cell frequencies were similar for 3 and 5&#x000a0;h peptide restimulation (Figure <xref rid="eji5988-supinfo-0001" ref-type="">S2D</xref>). Therefore, IFN&#x003b3;&#x02010;production by A2/M1<sub>58</sub>&#x02010;specific CD8<sup>+</sup> T&#x02010;cells was compared between nanovials and ICS at 3&#x000a0;h.</p><p>Ninety&#x02010;two percent of live CD3<sup>+</sup> T&#x02010;cells loaded on A2/M1<sub>58</sub>&#x02010;coated nanovials (median) were CD8<sup>+</sup> T&#x02010;cells, which was significantly higher than the median 38% A2/M1<sub>58</sub> tetramer<sup>+</sup>CD8<sup>+</sup> T&#x02010;cells in the ICS (% of live CD3<sup>+</sup> T&#x02010;cells) (Figure&#x000a0;<xref rid="eji5988-fig-0001" ref-type="fig">1D</xref>). However, a significantly higher number of A2/M1<sub>58</sub>&#x02010;tetramer <sup>+</sup>CD8<sup>+</sup> T&#x02010;cells was detected in the ICS (median 3136 cells) compared with nanovial&#x02010;bound CD8<sup>+</sup> T&#x02010;cells (median 575 cells). This indicates that although pHLA&#x02010;coated nanovials bind cells in a highly specific manner, not all epitope&#x02010;specific cells are captured from the target population (Figure&#x000a0;<xref rid="eji5988-fig-0001" ref-type="fig">1D</xref>). This observation was supported by significantly higher frequency and number of IFN&#x003b3;&#x02010;producing A2/M1<sub>58</sub>
<sup>+</sup>CD8<sup>+</sup> T&#x02010;cells in the ICS (median 50%, 1344 cells) versus nanovial&#x02010;bound IFN&#x003b3;&#x02010;secreting A2/M1<sub>58</sub>
<sup>+</sup>CD8<sup>+</sup> T&#x02010;cells (median 4%, 41 cells) (Figure&#x000a0;<xref rid="eji5988-fig-0001" ref-type="fig">1E</xref>).</p><p>To confirm that low cell&#x02010;nanovial binding did not result from inefficient nanovial&#x02010;coating with biotinylated A2/M1<sub>58</sub>&#x02010;monomers and anti&#x02010;IFN&#x003b3;, empty modified nanovials were stained with anti&#x02010;HLA&#x02010;A2&#x02010;FITC and anti&#x02010;IFN&#x003b3;&#x02010;APC after incubation with rIFN&#x003b3;. Our findings confirmed that nanovials were adequately coated with A2/M1<sub>58</sub> monomers and anti&#x02010;IFN&#x003b3; capture reagents (Figure <xref rid="eji5988-supinfo-0001" ref-type="">S2E</xref>). However, further optimization is required to enhance the capture of IFN&#x003b3;&#x02010;secreting epitope&#x02010;specific CD8<sup>+</sup> T&#x02010;cells, to replicate the binding efficiency observed in earlier studies [<xref rid="eji5988-bib-0010" ref-type="bibr">10</xref>]. Differences in IFN&#x003b3;&#x02010;production through intracellular accumulation (ICS) or secretion (nanovials) may be attributed to reduced numbers of IFN&#x003b3;&#x02010;secreting cells identified in the nanovial assay. Conversely, activated T&#x02010;cells may decrease their TCR expression, resulting in reduced avidity for the monomer&#x02010;coated nanovials. Indeed, tetramer staining of M1<sub>58&#x02013;66</sub>&#x02010;peptide and PMA/ionomycin stimulated cells in the ICS was less bright compared with the DMSO control (Figure&#x000a0;<xref rid="eji5988-fig-0001" ref-type="fig">1C</xref>; Figure <xref rid="eji5988-supinfo-0001" ref-type="">S2F</xref>). Co&#x02010;coating nanovials with additional capture reagents for molecules upregulated on activated T&#x02010;cells, like ICAM1, may increase the avidity of activated T&#x02010;cells [<xref rid="eji5988-bib-0013" ref-type="bibr">13</xref>].</p><p>Next, as proof&#x02010;of&#x02010;principle, nanovial&#x02010;bound IFN&#x003b3;&#x02010;secreting A2/M1<sub>58</sub>&#x02010;specific CD8<sup>+</sup> T&#x02010;cells were index&#x02010;sorted followed by paired&#x02010;TCR&#x003b1;&#x003b2; sequencing to link their paired&#x02010;TCR&#x003b1;&#x003b2; and IFN&#x003b3;&#x02010;secretion levels. Since ICS and TCR&#x003b1;&#x003b2;&#x02010;multiplex sequencing are incompatible, we compared TCR repertoires of index&#x02010;sorted nanovial&#x02010;bound IFN&#x003b3;&#x02010;secreting CD8<sup>+</sup> T&#x02010;cells and A2/M1<sub>58</sub>&#x02010;tetramer<sup>+</sup>CD8<sup>+</sup> T&#x02010;cells (Figure <xref rid="eji5988-supinfo-0001" ref-type="">S3A,B</xref>). Nanovial&#x02010;bound cells were sequenced using our standard TCR&#x003b1;&#x003b2;&#x02010;multiplex protocol [<xref rid="eji5988-bib-0001" ref-type="bibr">1</xref>]. TCRs consist of an alpha (&#x003b1;) and beta (&#x003b2;) chain, composed of a variable, junctional, and constant region. Their hypervariable complementarity&#x02010;determining region 3 (CDR3) determines the TCR specificity [<xref rid="eji5988-bib-0014" ref-type="bibr">14</xref>]. Circos analysis of TCR&#x003b1; and TCR&#x003b2; variable regions (TRAV and TRBV), revealed that nanovial&#x02010; and tetramer&#x02010;bound A2/M1<sub>58</sub>&#x02010;specific CD8<sup>+</sup> T&#x02010;cells shared 5/12 TRAV genes (including TRAV27) and were both dominated by TRBV19&#x02010;expressing clonotypes (Figure <xref rid="eji5988-supinfo-0001" ref-type="">S3C</xref>, Table <xref rid="eji5988-supinfo-0001" ref-type="">S1</xref>). Furthermore, CDR3&#x02010;motifs overlapped between nanovial&#x02010; and tetramer&#x02010;bound A2/M1<sub>58</sub>&#x02010;specific CD8<sup>+</sup> T&#x02010;cells (Figure <xref rid="eji5988-supinfo-0001" ref-type="">S3D</xref>). Importantly, TRAV27, TRBV19, and the CDR3&#x003b2;&#x02010;(I)RS&#x02010;motif are characteristic of high&#x02010;affinity A2/M1<sub>58</sub>&#x02010;specific clonotypes [<xref rid="eji5988-bib-0001" ref-type="bibr">1</xref>, <xref rid="eji5988-bib-0012" ref-type="bibr">12</xref>, <xref rid="eji5988-bib-0015" ref-type="bibr">15</xref>], confirming that nanovial&#x02010;bound CD8<sup>+</sup> T&#x02010;cells were A2/M1<sub>58</sub>&#x02010;specific. Overall, four paired&#x02010;TCR&#x003b1;&#x003b2; clonotypes were shared between nanovial&#x02010; and tetramer&#x02010;bound A2/M1<sub>58</sub>&#x02010;specific CD8<sup>+</sup> T&#x02010;cells (Figure <xref rid="eji5988-supinfo-0001" ref-type="">S3E</xref>). To link paired&#x02010;TCR&#x003b1;&#x003b2; clonotypes with their IFN&#x003b3;&#x02010;secretion level, index&#x02010;sorted nanovial&#x02010;bound A2/M1<sub>58</sub>&#x02010;specific CD8<sup>+</sup> T&#x02010;cells were divided into low, medium, and high IFN&#x003b3;&#x02010;secreting populations. The &#x0201c;bottom&#x0201d; gate contains cells with anti&#x02010;IFN&#x003b3; stained cell surfaces rather than secreted IFN&#x003b3; [<xref rid="eji5988-bib-0010" ref-type="bibr">10</xref>] (Figure <xref rid="eji5988-supinfo-0001" ref-type="">S3B</xref>). Paired&#x02010;TCR&#x003b1;&#x003b2; clonotypes were shared between IFN&#x003b3;&#x02010;secreting populations, but only one clonotype was detected among all IFN&#x003b3; populations (Figure <xref rid="eji5988-supinfo-0001" ref-type="">S3F&#x02013;G</xref>; clone&#x02010;ID &#x0201c;A&#x0201d;, Table <xref rid="eji5988-supinfo-0001" ref-type="">S1</xref>).</p><p>Overall, nanovials are a promising tool to link cytokine secretion by epitope&#x02010;specific CD8<sup>+</sup> T&#x02010;cells to their paired TCR&#x003b1;&#x003b2;. However, additional optimization is needed to further improve the capture and activation of epitope&#x02010;specific CD8<sup>+</sup> T&#x02010;cells. Although we identified TCR overlap between nanovial&#x02010; and tetramer&#x02010;bound A2/M1<sub>58</sub>&#x02010;specific CD8<sup>+</sup> T&#x02010;cell populations, larger studies are needed to conclusively link specific TCR&#x003b1;&#x003b2;&#x02010;features to a specific IFN&#x003b3;&#x02010;secretion level. Importantly, the nanovial assay can be extended to capture additional secreted cytokines, including TNF and IL&#x02010;2, to study the polyfunctionality of epitope&#x02010;specific T&#x02010;cells [<xref rid="eji5988-bib-0010" ref-type="bibr">10</xref>], while staining of additional surface markers allows further in&#x02010;depth phenotypic characterization of cytokine&#x02010;secreting cells.</p><sec sec-type="COI-statement" id="eji5988-sec-0030"><title>Conflicts of Interest</title><p>D. D. C. and the Regents of the University of California have financial interests in Partillion Bioscience Corporation, which sells nanovials. H. A. M. is a consultant for Ena Respiratory. The remaining authors declare no conflicts of interest.</p></sec><sec sec-type="supplementary-material"><title>Supporting information</title><supplementary-material id="eji5988-supinfo-0001" position="float" content-type="local-data"/><supplementary-material id="eji5988-supitem-0001" position="float" content-type="local-data"><caption><p>Supporting Information</p></caption><media xlink:href="EJI-55-e202451666-s002.docx"/></supplementary-material><supplementary-material id="eji5988-supitem-0002" position="float" content-type="local-data"><caption><p>Supporting Information</p></caption><media xlink:href="EJI-55-e202451666-s001.pdf"/></supplementary-material><supplementary-material id="eji5988-supitem-0003" position="float" content-type="local-data"><caption><p>Supporting Information</p></caption><media xlink:href="EJI-55-e202451666-s003.xlsx"/></supplementary-material></sec></body><back><ack id="eji5988-sec-0020"><title>Acknowledgments</title><p>We thank Prof. Kedzierska and the Melbourne Cytometry Platform for technical support and assistance. The study was funded by the Sanquin Blood Supply project grant (PPOC, L2506). CES is supported by the ARC&#x02010;DECRA Fellowship (#DE220100185) and UoM&#x02010;Establishment Grant. DDC acknowledges support from the Chan Zuckerberg Initiative Donor Advised Fund (2023&#x02010;332386, CZI DAF), an advised fund of the Silicon Valley Community Foundation.</p><p>Open access publishing facilitated by The University of Melbourne, as part of the Wiley &#x02010; The University of Melbourne agreement via the Council of Australian University Librarians.</p></ack><sec sec-type="data-availability" id="eji5988-sec-0050"><title>Data Availability Statement</title><p>TCR data are included in Table <xref rid="eji5988-supinfo-0001" ref-type="">S1</xref>. Source data are deposited in Mendeley [DOI:10.17632/ptnrwb9kyk.1]. Additional data are available from the corresponding author upon reasonable request.</p></sec><ref-list id="eji5988-bibl-0001"><title>References</title><ref id="eji5988-bib-0001"><label>1</label><mixed-citation publication-type="journal" id="eji5988-cite-0001">
<string-name>
<given-names>C. E.</given-names>
<surname>van de Sandt</surname>
</string-name>, <string-name>
<given-names>T. H. O.</given-names>
<surname>Nguyen</surname>
</string-name>, <string-name>
<given-names>N. A.</given-names>
<surname>Gherardin</surname>
</string-name>, et&#x000a0;al., &#x0201c;<article-title>Newborn and Child&#x02010;Like Molecular Signatures in Older Adults Stem From TCR Shifts Across human Lifespan</article-title>,&#x0201d; <source>Nature Immunology</source>
<volume>24</volume> (<year>2023</year>): <fpage>1890</fpage>&#x02013;<lpage>1907</lpage>.<pub-id pub-id-type="pmid">37749325</pub-id>
</mixed-citation></ref><ref id="eji5988-bib-0002"><label>2</label><mixed-citation publication-type="journal" id="eji5988-cite-0002">
<string-name>
<given-names>C. E.</given-names>
<surname>van de Sandt</surname>
</string-name>, <string-name>
<given-names>J. H. C. M.</given-names>
<surname>Kreijtz</surname>
</string-name>, <string-name>
<given-names>M. M.</given-names>
<surname>Geelhoed&#x02010;Mieras</surname>
</string-name>, et&#x000a0;al., &#x0201c;<article-title>Differential Recognition of Influenza A Viruses by M158&#x02010;66 Epitope&#x02010;Specific CD8+ T Cells Is Determined by Extraepitopic Amino Acid Residues</article-title>,&#x0201d; <source>Journal of Virology</source>
<volume>90</volume> (<year>2015</year>): <fpage>1009</fpage>&#x02013;<lpage>1022</lpage>.<pub-id pub-id-type="pmid">26537686</pub-id>
</mixed-citation></ref><ref id="eji5988-bib-0003"><label>3</label><mixed-citation publication-type="journal" id="eji5988-cite-0003">
<string-name>
<given-names>I.</given-names>
<surname>Messaoudi</surname>
</string-name>, <string-name>
<given-names>J. A.</given-names>
<surname>Guevara Pati&#x000f1;o</surname>
</string-name>, <string-name>
<given-names>R.</given-names>
<surname>Dyall</surname>
</string-name>, and <string-name>
<given-names>J.</given-names>
<surname>Lemaoult</surname>
</string-name>, <string-name>
<given-names>J.</given-names>
<surname>Nikolich&#x02010;Zugich</surname>
</string-name>, &#x0201c;<article-title>Direct Link Between mhc Polymorphism, T Cell Avidity, and Diversity in Immune Defense</article-title>,&#x0201d; <source>Science (1979)</source>
<volume>298</volume> (<year>2002</year>): <fpage>1797</fpage>&#x02013;<lpage>1800</lpage>.</mixed-citation></ref><ref id="eji5988-bib-0004"><label>4</label><mixed-citation publication-type="journal" id="eji5988-cite-0004">
<string-name>
<given-names>D. G.</given-names>
<surname>Chen</surname>
</string-name>, <string-name>
<given-names>J.</given-names>
<surname>Xie</surname>
</string-name>, <string-name>
<given-names>Y.</given-names>
<surname>Su</surname>
</string-name>, and <string-name>
<given-names>J. R.</given-names>
<surname>Heath</surname>
</string-name>, &#x0201c;<article-title>T Cell Receptor Sequences Are the Dominant Factor Contributing to the Phenotype of CD8+ T Cells With Specificities Against Immunogenic Viral Antigens</article-title>,&#x0201d; <source>Cell Reports</source>
<volume>42</volume> (<year>2023</year>): <elocation-id>113279</elocation-id>.<pub-id pub-id-type="pmid">37883974</pub-id>
</mixed-citation></ref><ref id="eji5988-bib-0005"><label>5</label><mixed-citation publication-type="journal" id="eji5988-cite-0005">
<string-name>
<given-names>L. C.</given-names>
<surname>Rowntree</surname>
</string-name>, <string-name>
<given-names>T. H. O.</given-names>
<surname>Nguyen</surname>
</string-name>, <string-name>
<given-names>L.</given-names>
<surname>Kedzierski</surname>
</string-name>, et&#x000a0;al., &#x0201c;<article-title>SARS&#x02010;CoV&#x02010;2&#x02010;specific T Cell Memory With Common TCRab Motifs Is Established in Unvaccinated Children Who Seroconvert After Infection</article-title>,&#x0201d; <source>Immunity</source>
<volume>55</volume> (<year>2022</year>): <fpage>1299</fpage>&#x02013;<lpage>1315</lpage>.<pub-id pub-id-type="pmid">35750048</pub-id>
</mixed-citation></ref><ref id="eji5988-bib-0006"><label>6</label><mixed-citation publication-type="journal" id="eji5988-cite-0006">
<string-name>
<given-names>B. P.</given-names>
<surname>Nicolet</surname>
</string-name>, <string-name>
<given-names>A.</given-names>
<surname>Guislain</surname>
</string-name>, <string-name>
<given-names>F. P. J.</given-names>
<surname>van Alphen</surname>
</string-name>, et&#x000a0;al., &#x0201c;<article-title>CD29 Identifies IFN&#x02010;&#x003b3;&#x02010;Producing Human CD8+ T Cells With an Increased Cytotoxic Potential</article-title>,&#x0201d; <source>Proceedings of the National Academy of Sciences</source>
<volume>117</volume> (<year>2020</year>): <fpage>6686</fpage>&#x02013;<lpage>6696</lpage>.</mixed-citation></ref><ref id="eji5988-bib-0007"><label>7</label><mixed-citation publication-type="journal" id="eji5988-cite-0007">
<string-name>
<given-names>A.</given-names>
<surname>Han</surname>
</string-name>, <string-name>
<given-names>J.</given-names>
<surname>Glanville</surname>
</string-name>, <string-name>
<given-names>L.</given-names>
<surname>Hansmann</surname>
</string-name>, and <string-name>
<given-names>M. M.</given-names>
<surname>Davis</surname>
</string-name>, &#x0201c;<article-title>Linking T&#x02010;Cell Receptor Sequence to Functional Phenotype at the Single&#x02010;Cell Level</article-title>,&#x0201d; <source>Nature Biotechnology</source>
<volume>32</volume> (<year>2014</year>): <fpage>684</fpage>&#x02013;<lpage>692</lpage>.</mixed-citation></ref><ref id="eji5988-bib-0008"><label>8</label><mixed-citation publication-type="journal" id="eji5988-cite-0008">
<string-name>
<given-names>R.</given-names>
<surname>Dimatteo</surname>
</string-name> and <string-name>
<given-names>C. D.</given-names>
<surname>Di</surname>
</string-name>, &#x0201c;<article-title>IL&#x02010;2 Secretion&#x02010;based Sorting of Single T Cells Using High&#x02010;Throughput Microfluidic On&#x02010;Cell Cytokine Capture</article-title>,&#x0201d; <source>Lab on A Chip</source>
<volume>22</volume> (<year>2022</year>): <fpage>1576</fpage>&#x02013;<lpage>1583</lpage>.<pub-id pub-id-type="pmid">35293406</pub-id>
</mixed-citation></ref><ref id="eji5988-bib-0009"><label>9</label><mixed-citation publication-type="journal" id="eji5988-cite-0009">
<string-name>
<given-names>J.</given-names>
<surname>De Rutte</surname>
</string-name>, <string-name>
<given-names>R.</given-names>
<surname>Dimatteo</surname>
</string-name>, <string-name>
<given-names>M. M.</given-names>
<surname>Archang</surname>
</string-name>, et&#x000a0;al., &#x0201c;<article-title>Suspendable Hydrogel Nanovials for Massively Parallel Single&#x02010;Cell Functional Analysis and Sorting</article-title>,&#x0201d; <source>ACS Nano</source>
<volume>16</volume> (<year>2021</year>): <fpage>7242</fpage>&#x02013;<lpage>7257</lpage>.</mixed-citation></ref><ref id="eji5988-bib-0010"><label>10</label><mixed-citation publication-type="journal" id="eji5988-cite-0010">
<string-name>
<given-names>D.</given-names>
<surname>Koo</surname>
</string-name>, <string-name>
<given-names>Z.</given-names>
<surname>Mao</surname>
</string-name>, <string-name>
<given-names>R.</given-names>
<surname>Dimatteo</surname>
</string-name>, et&#x000a0;al., &#x0201c;<article-title>Defining T Cell Receptor Repertoires Using Nanovial&#x02010;Based Binding and Functional Screening</article-title>,&#x0201d; <source>Proceedings of the National Academy of Sciences</source>
<volume>121</volume> (<year>2024</year>): <elocation-id>e2320442121</elocation-id>.</mixed-citation></ref><ref id="eji5988-bib-0011"><label>11</label><mixed-citation publication-type="journal" id="eji5988-cite-0011">
<string-name>
<given-names>I. Y.</given-names>
<surname>Song</surname>
</string-name>, <string-name>
<given-names>A.</given-names>
<surname>Gil</surname>
</string-name>, <string-name>
<given-names>R.</given-names>
<surname>Mishra</surname>
</string-name>, <string-name>
<given-names>D.</given-names>
<surname>Ghersi</surname>
</string-name>, <string-name>
<given-names>L. K.</given-names>
<surname>Selin</surname>
</string-name>, and <string-name>
<given-names>L. J.</given-names>
<surname>Stern</surname>
</string-name>, &#x0201c;<article-title>Broad TCR Repertoire and Diverse Structural Solutions for Recognition of an Immunodominant CD8+ T Cell Epitope</article-title>,&#x0201d; <source>Nature structural &#x00026; molecular biology</source>
<volume>24</volume> (<year>2017</year>): <fpage>395</fpage>&#x02013;<lpage>406</lpage>.</mixed-citation></ref><ref id="eji5988-bib-0012"><label>12</label><mixed-citation publication-type="journal" id="eji5988-cite-0012">
<string-name>
<given-names>G. B. E.</given-names>
<surname>Stewart&#x02010;Jones</surname>
</string-name>, <string-name>
<given-names>A. J.</given-names>
<surname>McMichael</surname>
</string-name>, <string-name>
<given-names>J. I.</given-names>
<surname>Bell</surname>
</string-name>, <string-name>
<given-names>D. I.</given-names>
<surname>Stuart</surname>
</string-name>, and <string-name>
<given-names>E. Y.</given-names>
<surname>Jones</surname>
</string-name>, &#x0201c;<article-title>A Structural Basis for Immunodominant human T Cell Receptor Recognition</article-title>,&#x0201d; <source>Nature Immunology</source>
<volume>4</volume> (<year>2003</year>): <fpage>657</fpage>&#x02013;<lpage>663</lpage>.<pub-id pub-id-type="pmid">12796775</pub-id>
</mixed-citation></ref><ref id="eji5988-bib-0013"><label>13</label><mixed-citation publication-type="journal" id="eji5988-cite-0013">
<string-name>
<given-names>S.</given-names>
<surname>Dimitrov</surname>
</string-name>, <string-name>
<given-names>C.</given-names>
<surname>Gouttefangeas</surname>
</string-name>, <string-name>
<given-names>L.</given-names>
<surname>Besedovsky</surname>
</string-name>, et&#x000a0;al., &#x0201c;<article-title>Activated Integrins Identify Functional Antigen&#x02010;Specific CD8+ T Cells Within Minutes After Antigen Stimulation</article-title>,&#x0201d; <source>Proceedings of the National Academy of Sciences</source>
<volume>115</volume> (<year>2018</year>): <fpage>E5536</fpage>&#x02013;<lpage>E5545</lpage>.</mixed-citation></ref><ref id="eji5988-bib-0014"><label>14</label><mixed-citation publication-type="journal" id="eji5988-cite-0014">
<string-name>
<given-names>S. J.</given-names>
<surname>Turner</surname>
</string-name>, <string-name>
<given-names>P. C.</given-names>
<surname>Doherty</surname>
</string-name>, <string-name>
<given-names>J.</given-names>
<surname>McCluskey</surname>
</string-name>, and <string-name>
<given-names>J.</given-names>
<surname>Rossjohn</surname>
</string-name>, &#x0201c;<article-title>Structural Determinants of T&#x02010;Cell Receptor Bias in Immunity</article-title>,&#x0201d; <source>Nature Reviews Immunology</source>
<volume>6</volume> (<year>2006</year>): <fpage>883</fpage>&#x02013;<lpage>894</lpage>.</mixed-citation></ref><ref id="eji5988-bib-0015"><label>15</label><mixed-citation publication-type="journal" id="eji5988-cite-0015">
<string-name>
<given-names>T. M.</given-names>
<surname>Lawson</surname>
</string-name>, <string-name>
<given-names>S.</given-names>
<surname>Man</surname>
</string-name>, <string-name>
<given-names>S.</given-names>
<surname>Williams</surname>
</string-name>, <string-name>
<given-names>A. C. M.</given-names>
<surname>Boon</surname>
</string-name>, <string-name>
<given-names>M.</given-names>
<surname>Zambon</surname>
</string-name>, and <string-name>
<given-names>L. K.</given-names>
<surname>Borysiewicz</surname>
</string-name>, &#x0201c;<article-title>Influenza A Antigen Exposure Selects Dominant V&#x003b2;17+ TCR in Human CD8+ Cytotoxic T Cell Responses</article-title>,&#x0201d; <source>International Immunology</source>
<volume>13</volume> (<year>2001</year>): <fpage>1373</fpage>&#x02013;<lpage>1381</lpage>.<pub-id pub-id-type="pmid">11675369</pub-id>
</mixed-citation></ref></ref-list></back></article>